Table 1.
Demographic and clinical information at baseline
| MR-WM group (n = 28) | WM-MR group (n = 27) | p value | |
|---|---|---|---|
| age | 22 ± 10 | 23 ± 7 | p = 0.97 |
| Sex (no. female) | 14 | 13 | p = 0.91 |
| DAQ (craving) | 2.92 ± 0.79 (S.D) | 3.33 ± 1.11 | p = 0.12 |
| Desire for alcohol | 3.12 ± 0.99 (S.D) | 2.9 ± 0.97 (S.D) | |
| Negative reinforcement | 3.43 ± 1.21 (S.D) | 3.69 ± 1.41 (S.D) | |
| (Loss in) control | 2.48 ± 1.13 (S.D) | 3.5 ± 3.00 (S.D.) | |
| RCQ (readiness to change) | p = 0.61 | ||
| Pre-contemplation phase | 4% (n = 1) | ||
| Contemplation phase | 46% (n = 13) | 44% (n = 12) | |
| Action phase | 50% (n = 14) | 56% (n = 15) | |
| Substance usea | |||
| Weekly alcohol intakeb | 20 ± 13.13 (IQR) | 23.5 ± 13 (IQR) | p = 0.50 |
| MDMA use in past 12 months | |||
| 1–10 times | 36% (n = 10) | 41% (n = 11) | p = 0.048 |
| Cannabis use | p = 0.023 | ||
| 1–20 times | 39% (n = 11) | 44% (n = 12) | |
| 21–40 times | 18% (n = 5) | 33% (n = 9) | |
| > 40 times | 14% (n = 4) | 11% (n = 3) | |
| AUDIT (alcohol use severity) | 17 ± 6.75 (IQR) | 21 ± 7 (IQR) | p = 0.11 |
| CUDIT (cannabis use severity) | 0 ± 3 (IQR) | 5 ± 9 (IQR) | p = 0.019 |
| FTND (smoking severity) | 22 ± 10.75 (IQR) | 18 ± 19 (IQR) | p = 0.06 |
Significance level is p<0.05
aOnly drug use that differed between groups is shown in this table
bNumber of standard units p<0.05